Counterfeit Keytruda (pembrolizumab), an immunotherapy cancer treatment, has infiltrated pharmaceutical supply chains and reached patients and hospitals. The fake medications pose potentially fatal consequences for cancer patients depending on authentic treatment, indicating significant health system vulnerability to pharmaceutical fraud.